Oculus Innovative Sciences, Inc., has announced the sale of its remaining 1.65 million shares of Ruthigen.
The stock was sold to an investor group at $2.75 per share for non-dilutive funding of $4.5 million.
View the full release here.
Oculus Innovative Sciences, Inc., has announced the sale of its remaining 1.65 million shares of Ruthigen.
The stock was sold to an investor group at $2.75 per share for non-dilutive funding of $4.5 million.
View the full release here.